XML 81 R51.htm IDEA: XBRL DOCUMENT v3.26.1
Corporate and Group information - Summary of Subsidiaries (Detail)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Pharvaris Holdings BV [member]    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Name Pharvaris Holdings B.V.  
Legal seat Leiden  
Country of incorporation The Netherlands  
% of equity interest 100.00% 100.00%
Pharvaris Netherlands BV [member]    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Name Pharvaris Netherlands B.V.  
Legal seat Leiden  
Country of incorporation The Netherlands  
% of equity interest 100.00% 100.00%
Pharvaris Inc [member]    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Name Pharvaris, Inc.  
Legal seat Delaware  
Country of incorporation United States of America  
% of equity interest 100.00% 100.00%
Pharvaris GmbH [member]    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Name Pharvaris GmbH  
Legal seat Zug  
Country of incorporation Switzerland  
% of equity interest 100.00% 100.00%
Pharvaris Pharmaceuticals, Inc [member]    
Disclosure Of Significant Investments In Subsidiaries [Line Items]    
Name [1] Pharvaris Pharmaceuticals, Inc.  
Legal seat [1] Delaware  
Country of incorporation [1] United States of America  
% of equity interest 100.00%  
[1]

*Pharvaris Pharmaceuticals, Inc was incorporated in June 2025